Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Differential Diagnosis Tools for HCPs
-
Hello! 2.4 of the Guidance on Branded Patient Information discusses how differential diagnosis information can be presented in a Branded Piece (even though such information would be discussing conditions for which the Product does not have an indication).
Does this still hold true for branded HCP pieces? Or would this content only be permissible for HCPs in unbranded pieces?
-
Hey @dmauri
While it’s not an outright no, in the context of a branded HCP pieces a diagnosis should already have been made prior to consideration of the product. If a piece with differential diagnosis was to be considered, it would have to be overtly clear that it was to ensure the proper patient selection and there was no inference of off-label use.
